Protectimmun's Project Finance Round

Protectimmun raised a round of funding on September 28, 2015. Investors include Janssen Pharmaceuticals.

Protectimmun focusses on new approaches in the prevention and therapy of allergic and chronic inflammatory diseases. Its innovative concept for product development is based on the identification of na…

Articles about Protectimmun's Project Finance Round: